China NT Pharma Group Company Limited 357,032, ,479,000 86,553,000 35,703, ,328, ,775,500 86,553, % 0.003% 0.005%

China NT Pharma Group Company Limited 中國泰凌醫藥集團有限公司 ( 於開曼群島註冊成立之有限公司 ) 股份代號 : 1011 全球發售獨家全球協調人及獨家保薦人聯席賬簿管理人及聯席牽頭經辦人

China NT Pharma Group Company Limited 357,032,000 270,479,000 86,553,000 35,703,500 321,328,500 234,775,500 86,553,000 6.00 1% 0.003% 0.005% 0.00000008 1011 342C 6.00 4.54 www.hkexnews.hk (i) 144A (ii) S

(1) www.hkeipo.hk 4... 2... (3)...... 5...... www.ntpharma.com www.hkexnews.hk (6)... www.ntpharma.com www.hkexnews.hk www.tricor.com.hk/ipo/result... 7... 8...

(1)... (1) (2) 8 8. (3) 3. (4) www.hkeipo.hk (5) (6) www.hkexnews.hk (7) (8)

...... i iii... 1... 21... 28... 33... 34... 60... 63... 66... 69... 71... 90

... 104... 116... 177... 183... 190... 192... 194... 253... 255... 262... 271... I-1... II-1... III-1... IV-1 TPG... V-1 TPG... VI-1... VII-1... VIII-1... IX-1

1 2 1 18.0%23.4%6.9% 10.7% 1 8.7% 1 II 64% 54% II 79% 72% 3 1 Frost & Sullivan II II II II 2 Frost & Sullivan 3 Frost & Sullivan

2 26,5003,500900 70% 4 1,250 20% 4 33297 99396 19 15 6 HIB 73% II27% 4

(37.1%) II A+C 57.1% 34.9%28.0% 47.6% MENET 5 5 MENET

42.9% 65.1% 53.8% 86.3% IMS70 15 I II II II 64% I 20.7% II 24.4% 31.3%39.3% 6 930.41,524.6 28.0% II 15.2% 74 6 Frost & SullivanII II

Frost & SullivanII 7.6% 1,414.02,395.0 2,668.037.4% 235.1479.9 663.2 68.0% 150 120 28.4% 7 662.2234.0 240 1.8% 2.4% 3412592 69183127 6090 60180 7

643.5 a. 188.9 82.8% b. 41 c. d. e. 15.9% 1,566.7 13.9% 37.7 251.3 383.2

A+C Meningococcal ACYW 19.7% 13.9% 18.5%

34.2% 61.4% 38.2% 64.7%42.9% 66.5%II I 3.0% 5.1% 1.8%0.6% 0.9% 0.4% 162 29% 28% 15.8%50.3% 1.6%5.2% 29% 28% 57.2 78.0 55.336.9 26.6 65.5 29.0

58.2% 43.2% 47.5% TPG TPG NT Holdings TPGANT Holdings TPG TPG20.32% NT Holdings Golden Base TPG 250 TPG

Golden Base 650 250 Golden BaseTPG 24.8 16.9 6.3 0.7

(i) (ii) (iii) (iv)

II II

... 1,413,985 2,395,038 2,667,978... (1,178,904) (1,915,167) (2,004,775) (1)... 235,081 479,871 663,203... 48,196 7,670 28,698... (44,311) (1,739) 8,148... (108,129) (237,418) (354,456)... (43,147) (55,999) (90,056) (1)... 87,690 192,385 255,537... (14,277) (17,128) (45,379)... 73,413 175,257 210,158... (20,150) (58,087) (80,748)... 53,263 117,170 129,410... 53,263 117,170 128,610... 800 (2)(3)... 53,263 117,170 129,410 (1) 7.9 (2) 12.3 (3) 4.1 24.8

... 158,797 234,188 288,076... 125,690 231,016 527,054... 575,514 1,213,754 1,738,213... 51,262 55,990 47,080... 67,803 212,240 154,913... 820,269 1,713,000 2,467,260... 979,066 1,947,188 2,755,336... 882 2,005 2,661... 882 2,005 2,661... 563,188 1,042,657 1,358,270... 186,497 440,719 833,687... 70,000 6,500... 12,823 54,931 51,941... 762,508 1,608,307 2,250,398... 763,390 1,610,312 2,253,059... 57,761 104,693 216,862... 200,546 321,746 487,147... 15,130 15,130 15,130... 215,676 336,876 502,277

1,256.0 5.27 25%314.0 5.27 25%314.0 5.27 70% 10%125.6 5.27

20%251.2 5.27 20%251.2 5.27 10% 437.9 5.27 65.7 5.27

... 6.5 7.6 1.00 0.8509 11.18

... 0.00600.0071 1,081,916,500 1.00= 0.8509 4.54 6.00 (1)... 4,912 6,491 (2)... 32.5 42.9 1.25 1.55 (3)... 1.47 1.82 (1) 1,081,916,500 (2) 4.54 6.00 1,081,916,500 (3) 1,081,916,500 4.54 6.00

NT Holdings Business Monitor International 140 22 1961

Golden Base Frost & Sullivan Frost & Sullivan Golden Base Golden Base Investment Limited www.hkeipo.hk www.hkeipo.hk 32

35,703,500 Golden Base IMS IMS Health Incorporated 321,328,500 234,775,500 86,553,000

MENET 270,479,000 NT BVI NT Pharma (Group) Co., Ltd NT Holdings NT Pharma (Holdings) Company Limited

53,554,000 15% Wyeth Inc. 144A S S 144A 144A

86,553,000 12,982,500 TPG Biotech TPG Star A NT Holdings 0.00000008 571 0.00000008 SmithKline Beecham Glaxo Wellcome 80% TPG TPG Biotech TPG Star TPG Biotech TPG Biotech III Jaguar Ltd.

TPG Star TPG Star Jaguar Ltd.

GMP

GSP ISO9001 PEG A+C A+C

Meningococcal ACYW PEG

- - I II AB

120150 534.3 1,110.8 1,566.754.6% 57.0% 56.9% 8.2 3.1 125 18328.4% 662.2234.0 56.6% 20.4%9.5% 13.5% 12 28.4% 240 1.8% 2.4% 643.5 188.9 82.8%

37.7 251.3 383.2 A+C Meningococcal ACYW 19.7% 13.9% 18.5% SmithKline Beecham

63.4% 65.6% 60.7% 44.1% 46.6% 46.5% 85.0% 86.5% 82.3%

20.1% 4.8%

II I 3.0% 5.1% 1.8% 0.6% 0.9% 0.4% 162 29% 28%15.8% 50.3%1.6% 5.2% 53.3 117.2 129.4

19.0% 26.2% 30.5%

28.1

500 48 (2-8 C) 100 80%

1 1 Frost & Sullivan II II II II

1,414.0 2,395.02,668.0 37.4%

24% 25% 1 2 138.6 27,031.2 100.0% 27.6%

137.9

74 II

I IIII II III II I

0.5% 20% 1% 1%

(H1N1) (H1N1) (H1N1)

25% (i) (ii) (iii) (iv) 25% 10% 10%

10% 50%

46.68%

1.65 3.62 5.27

1. 14A 2. 17.02(1)(b)1A 27 I 10(d) 17.02(1)(b) 1A 27 I342(1)(b) 10 (i) 64 57 (ii)

17.02(1)(b)1A 27 (i) D. 10(d) 17.02(1)(b)1A 27 (ii) (i) (1) (2) (3)(4) (iii) (iv) D. (v) 17.02(1)(b)1A 27 I10 (vi) 342AI10(d) (i) D. 10(d)

(ii) (i) (1) (2) (3)(4) (iii) I10

75 75 75 (i) (ii) 44B(1) Codan Trust Company (Cayman) Limited

1.000.84 7.79 1.00

23 1 23 A 69 6 3 E 23 1 23 A PMB370 500 West University Avenue E1 Paso Texas 79968 US 25 1 6 C 7 1 6 603 41A A 3 A1

8 52 8 52 2 68 8 52 2 68 8 13 8 11 1045 28-30

Conyers Dill & Pearman Cricket Square Hutchins Drive P.O. Box 2681 Grand Cayman KY1-1111 Cayman Islands 15 9 1515 32 10 8 398 10 1 10 45

XI 333 10 Cricket Square Hutchins Drive PO Box 2681 Grand Cayman KY1-1111 Cayman Islands 5 23 2301-3 www.ntpharma.com CPA FCCA 23 1 23 A 69 6 3 E

Codan Trust Company (Cayman) Limited Cricket Square, Hutchins Drive P.O. Box 2681 Grand Cayman, KY1-1111 Cayman Islands 28 26 12 6 606 418 38 268 22 399 59

Frost & Sullivan Frost & Sullivan Frost & Sullivan Frost & Sullivan Frost & Sullivan Frost & Sullivan Frost & Sullivan Frost & Sullivan 11,75919,10912.9% GDP16.5% GDP

16,456 29,678 15.9% GDP 476.0 115.8 786.2 246.0 65 65 7.5% 96.9 8.3% 109.6 Euromonitor International 71.1 72.6

Euromonitor International 1,94713,240Euromonitor International 22,972156,210 5,026 11,290 14.4% Euromonitor International 123Euromonitor International 81.1 552146.6 997 16.0%

%... 2,297.2 6,598.4 7,492.5 3.2%... 404.1 2,921.5 3,166.8 2.0%... 343.8 3,618.1 4,192.9 3.8%... 299.1 3,924.9 4,789.0 5.1%... 201.3 3,112.4 3,267.2 1.2%... 199.8 2,706.3 3,326.4 5.3%... 194.7 81.1 146.6 16.0%... 130.8 3,470.8 3,887.2 2.9%... 130.2 2,179.6 2,860.3 7.0% Euromonitor International Euromonitor International GDP 8% 11% Euromonitor International GDP4.1% (16.3%) (10.9%) GDP GDP Euromonitor International

(2009-2011) 90% 65

15 20 2.331% I II III

Frost & Sullivan 101 13 7.6 145.4 109.0 73.4 49.7 Frost & Sullivan 12033236 63 Frost & Sullivan Frost & Sullivan 66 123 23.1% 13.4 1,600

Frost & Sullivan 2% 3%27% Frost & SullivanII 2.7 4.8 21.1% H1N1 I IIIIII I II I III I II 33%

III I II... 2.5 4.1... 3.2 5.5... 3.7 6.4... 4.4 7.9... 20.7% 24.4% Frost & Sullivan II

Frost & Sullivan 3,534 28,407 II Frost & Sullivan 41 II II33%Frost & SullivanII Frost & Sullivan 41 7924.4% (%)... 4.1... 5.5 34.1... 6.4 16.4... 7.9 23.4 Frost & Sullivan

II II Frost & Sullivan II 74 Frost & Sullivan II 7.6% Frost & Sullivan Frost & SullivanZuellig Pharma Asia Pacific10 250 150 Frost & Sullivan 18.0%23.4%6.9%

10.7% 1 Frost & Sullivan Frost & Sullivan 1 II II

Frost & Sullivan 48 7323.3% Frost & Sullivan26 4224.2% (%) (%)... 2.6 55.0... 3.4 30.8 56.0... 4.2 23.5 57.9 Frost & Sullivan Frost & Sullivan Frost & Sullivan 4% 200 7 15 Frost & Sullivan

Frost & Sullivan 0.4% 8.7% Frost & Sullivan 2 4.7% Frost & Sullivan II270.0 480.0 21.1% Frost & Sullivan 37.1% Frost & Sullivan68.0 135.0 25.7% 100.0335.0 Frost & Sullivan A C 21% 27.9Frost & Sullivan 68.1% 91.9 Frost & Sullivan 2,000 Frost & Sullivan 7 1219.7% 300 Frost & Sullivan 500850 19.3% 2 II II

Business Monitor International 4683,19315.3% 15.3% Business Monitor International Business Monitor International 2,314 72.5% Business Monitor International 1,24016.9% 880 11.6%

Business Monitor International 2,001 62.7% 312 9.8% Business Monitor International 26.9%15.6% MENET 23.5% 17.4% 13.4% MENET IMS 2232.5%

IMS 20 Frost & Sullivan 97 93 70

IMS 70 15 Frost & Sullivan Frost & Sullivan Frost & Sullivan52,000 Frost & Sullivan Frost & Sullivan351,800 Frost & Sullivan Frost & SullivanFrost & Sullivan Frost & Sullivan Frost & Sullivan Frost & Sullivan

(a) (b) (c)

(d) (e) (f) (g) (h) (i)

GSP GSP GSP III I II II I II II II II II

80%

10 10 20

25%

10% 15% 18% 20% 22% 24% 25%24% 25% 17.0% *3%

3.0% 20.0%

SmithKline Beecham 80% 48 20,500 TPGTPG Biotech TPG StarNT Holdings NT Holdings 9.11% 18.21%ATPG 11 ISO9001

Smithkline Beecham Smithkline Beecham55 900 1,000 700 690 2,000

TPG NT Holdings TPG NT Holdings TPG A+C TPG

TPG TPGNT Holdings NT Holdings TPG NT Holdings Golden Base TPG TPG Biotech TPG Star9111821 A NT Holdings 9.11% 18.21% TPG Biotech TPG Star 8,333,333 16,666,667A TPG Biotech TPG Star5 10 TPG3,333,333 6,666,667 TPG NT HoldingsNT Holdings TPG TPGANT Holdings A NT HoldingsNT Holdings NT Holdings TPG A A TPGA TPG Biotech TPG Star452905 A A TPG Biotech TPG StarNT Holdings1,3632,726 A NT Holdings 12% 24%

TPG NT Holdings ANT Holdings TPG TPGNT Holdings NT HoldingsNT Holdings 0.01 125,0000.00000008 0.01 A 125,000 0.00000008 AGolden Base908,500,000 TPG Biotech170,375,000 A TPG Star340,750,000 A NT Holdings TPG Biotech TPG Star TPG 0.098400984 NT Holdings101,625,000 ATPG NT Holdings10 101,625,000 A NT Holdings 0.098400984 101,625,000 NT Holdings Golden Base101,625,000

NT Holdings NT Holdings Golden Base... 1,010,125,000 62.24% TPG Biotech... 204,249,661 12.59% A TPG Star... 408,500,339 25.17% A Golden Base TPG Biotech TPG Star Golden Base TPG A TPG TPGA TPG TPG NT HoldingsTPG TPG TPG TPGNT Holdings TPG Biotechnology Partners III L.P. TPG BiotechTPG Star L.P. TPG Star ANT Holdings ANT Holdings ANT Holdings TPGA

TPG NT HoldingsA TPG TPG NT Holdings TPG 30NT Holdings TPG Star TPG Biotech NT HoldingsTPG Star TPG Biotech ANT Holdings TPG NT Holdings TPG NT Holdings TPG TPG 37.8% 30 TPG TPG Golden Base... 505,062,500 46.68% TPG Biotech... 73,273,000 6.77% TPG Star... 146,549,000 13.55%... 357,032,000 33.00%

TPG TPG TPG TPG TPG NT Holdings TPG TPG TPG TPG TPGA Golden Base Golden Base NT Holdings 250 TPGANT Holdings 250Golden Base Golden Base TPGTPG Golden Base TPG TPG 15% TPG 20.32% TPG Golden Base TPG 35.32%TPG Golden Base TPG Golden Base TPG

TPG 650 250 Golden Base TPG TPG TPG Star TPG BiotechTPGTPG 480 TPG TPG NT Holdings NT Holdings NT Holdings90,614,362 90,614,362 5.6% NT Holdings 64 89,914,35789,914,357 NT Holdings 45,307,181 45,307,181 5.3% 70% NT Holdings

1. 2. 20% 3. Tai Ling Pharma Company Limited NT Holdings 626,250,000,000 0.00000008NT Holdings (a) Tai Ning Pharmaceutical (Investment) Company Limited Goldwise Resources Limited NTP (China) Investment Co., Limited NT Pharma (HK) Limited NT BVI NT Holdings 451.3NT BVI NT Holdings 21.4 NT BVI

NT Holdings 7 1 472.7 NT BVI NT Holdings9 1 (b) (c) NT Holdings NT BVINT Holdings 811,437,499 0.00000008 811,437,500NT Holdings NT Holdings Golden Base TPG Biotech TPG StarGolden Base TPG Biotech TPG Star NT Holdings Golden Base... 505,062,500 62.24% TPG Biotech... 102,124,830 12.59% TPG Star... 204,250,170 25.17%

1. 2. 20%

1 2 1 18.0%23.4%6.9% 10.7% 1 8.7% 1 II 64% 54% II 79% 72% 3 2 26,5003,500900 70% 4 1,250 20% 4 1 Frost & Sullivan II II II II 2 Frost & Sullivan 3 Frost & Sullivan 4

33297 99396 1915 6 HIB 73% II27% (37.1%) II A+C 57.1% 34.9% 28.0% 47.6%

MENET 5 42.9% 65.1% 53.8% 86.3% IMS70 15 23 23 5 MENET

I II II II64% I 20.7% II 24.4% 31.3%39.3% 6 930.41,524.6 28.0% II 15.2% 6 Frost & Sullivan

74 Frost & SullivanII 7.6% 1,414.02,395.0 2,668.0 %... 1,413,985 2,395,038 2,667,978 37.4... 841,334 1,230,340 1,167,767 17.8... 89,093 249,447 356,788 100.1... 184,059 625,493 838,562 113.4... 299,499 289,758 304,861 0.9... 87,690 192,385 255,537 70.7 1... 40,626 47,100 44,970 5.2... 9,771 60,216 64,888 157.7... 46,220 103,399 194,741 105.3... 12,862 13,119 10,255 (10.7) 1

II 12.9% 8,500 I 6 14 III I 20.7% II 24.4% II 64% II IMS 20 10

IMS70 15 Frost & Sullivan 0.4% 8.7% 7 Frost & Sullivan II 18.0% 23.4% 8 28.0% II15.2% 4.0% 10.7% 16.6% 24.9% 118.6 11% 7 Frost & Sullivan II II 8 Frost & Sullivan II II

142.2 13% 2,80020,500 90% 3804,000 48 (Jiangsu Pharmaceutical Quality Control Society) 9 33297 5 90% II37.1% 9 Frost & Sullivan

II54% II 22%480 A+C 90 II ACYW4 II 34.9% 850

26,5003,500900 10 70%1,250 10 20% 8 17 11... 34.2% 29.0% 19.7% (1) (1) (1)... 46.6% 35.7% 31.4% (1) (1) (1)... 35.0% 24.3% 12.9% (1) (1) (2)... 18.0% 12.4% 8.1% (2) (3) (4) MENET 10 11

1881 6133512 65% 15 75% 60%

21,000 73% 4,20038,000

85% 20510

12 II 54% % % %... 841,334 59.5 1,230,340 51.4 1,167,767 43.8... 89,093 6.3 249,447 10.4 356,788 13.4... 930,427 65.8 1,479,787 61.8 1,524,555 57.2 51.4% 43.8% Frost & Sullivan 23.4% 13 6.9% 10.7% II64% 1915 6 73% II 12 Frost & Sullivan II II II II 13 IIII

27% 48

... 33.3% 40.0% 37.9%... 31.4% 23.4% 27.5%... 24.5% 22.6% 20.2%... 7.4% 9.7% 9.5%... 3.4% 4.3% 4.9%... 100% 100% 100% 50

A+C AC

(i) (ii) (iii) (iv) 90 60 180 1915 6

I II 15 II B 6 II B 6 II 3 5 II 18 24 1 II 1 19 II 8 II I 24 3 II 6 3 II 3 II AC 3 5 II MF59-65 II 6 II I

I II II PCECV II I III 50.2% 37.9% 31.2% 2-8 48

100 20% 6.2 9.4 19.1

19 (Jiangsu Quality Control Society) 48 24

7,778 12,972 28,500

2,800 542 14 73%II 87% 1 5% 90 60 120 28.4% 240 1.8% 2.4% 14

542109

... 225 732,684 51.8 385 1,053,605 44.0 542 1,107,560 41.5... 66 197,743 14.0 105 426,182 17.8 109 416,995 15.6 15... 201 691,831 48.9 200 904,375 37.8 251 875,309 32.8... 57 149,503 10.6 66 325,965 13.6 80 292,458 11.0 60 120 90 15

8.7% 16 20,500 II (1) 131 (2) 16 Frost & Sullivan II II

% % %... 89,093 6.3 249,447 10.4 356,788 13.4

62235 20,500 1150 590%

II 0 15 II 16 A+C A+C 2 80 18 200 ACYW ACYW 2 200

20,500... 4,000 10,000 2,500... 8,000 18,000 20,500 % % %... 184,059 13.0 625,493 26.1 838,562 31.4... 299,499 21.2 289,758 12.1 304,861 11.4

396 26,5003,500 900 17 70%1,250 15 20% 30 90 90 17

17 12.5% 24.2% 28.5% 36.6% 63.2% 66.6%................. MENET 34.2%19.7% 74% 41% 1,788

MENET 46.6% 31.4% 48% 1,140,000 1,656,00020.5% 309 MEMET 18.0% 8.1% 407,000 760,00036.6% 706 507,000 1,487,00071.3% MEMET 35.0% 12.9% 153

1,419,000 6,930,000121.0% 1,186 2.4% 0.1%...... PEG

AIDS-KSPEG 50 50 50 135 169186 90

26.6 12.18 22.13 15.92 GMP

... 2 74.8 2 100 2 120... 2 32.5 2 65 2 80 (1)... 1 150 113 75.4%... 2 20 15.5 78.9% (1) 300 8 300 22

1563 44 18 27 15 Yiling Yiliang 27 10 19 0.3 15.8 0.6 26.9... 0.9 36.6 1.2 45.7... 15 9.9... 30 17.0... 0.5 57.7... 1.0 98.1 2.0 166.8... 0.6 21.0... 1.2 38.0... 0.2 2.0... 0.4 4.4 18 19

13.3% 6.6% 7.4% 4.5% 2.5% 3.2% 80% 20% 800,000 800,000 50 60

210.2 224.7 211.4 3045

2.4 3.7 5.1

29.1% 28.5% 22.1% 9.9% 9.1% 7.3% 542109 20 20

2,80020,500 13.4% 2.4% 17 88.4% 85.9% 97.8% 67.2% 70.4% 65.5% State Pharmaceutical (Holdings) Limited

Frost & Sullivan II IMS 63.4% 65.6% 60.7% 44.1% 46.6% 46.5% 67.2% 70.4% 65.5% 7.9

Frost & Sullivan 10 Frost & Sullivan 250 150 Frost & Sullivan31.3%39.3% Frost & Sullivan 4%200 7 15 Frost & Sullivan Frost & Sullivan 48 73 23.3%

19 GSP20

(i)(ii) 20 6221,055 1,201... 446 37.1%... 383 31.9%... 229 19.1%... 82 6.8%... 61 5.1%... 1,201 100.0%

56.7 89.0 154.7 4.0% 3.7% 5.8%

12,816 450,000 43,807

B. 107,920.04 27,031.22 35.8 27,031.22 107,920.04

19 11,735.8

II i) III ii) II III iii) II

1 II 6840 371 II III6840 6845 6864 6865 GMP

GMP II II III 171

46.68% (a) (b) (i) 10% (ii) 5% (i) (ii) 30% (a)

(b) (i) (ii) (i) (ii) (i) (ii) (iii) TPG 8.10TPG Star TPG Biotech (i) (ii)

(iii) (iv) (v) (vi) (vii) Golden Base

28NT Holdings (i) (ii) (iii) 20% 14A

9.9 15.2 13.19.9 15.2 10%20% 20.1 26.6 35.1 (i) (ii) (iii) 9.9 15.2 13.1 20.1 26.6 35.1 14A.34(1)

14A.07 0.1% 5% 14A.45 14A.47 14A 14A.35(1) 14A.35(2) 14A.36 14A.37 14A.38 14A.39 14A.40

... 47... 46... 47... 54... 48... 52... 61... 60 47 15 46

Australian Business Lawyers H 438 1886 2868 3833 1733881 631 47 54 Allen Henry Moffitt 48TPG Growth Capital (Asia) LimitedTPG Morningside Technologies Inc LimitedMorningside Morningside Corporate Governance Award Organizing Committee Corporate Finance Committee

52 Solomon Systech (International) Limited2878 390 891 460 J.P. Morgan 188 823 821 Chartered Association of Certified Accountants Hong Kong Society of Accountants 61 494CEI Contract Manufacturing LimitedCEI Spencer Stuart & Associates16 1172 Tristate Holdings Limited458 112

MIT Corporation 60 Gairdner International Award Cresson Medal of Franklin Institute XII Sanremo International Award for Genetic Research (Distinguished Scientist Award from the Medical Research Council, Canada) Killam Prize of Canada Council European Cystic Fibrosis Society Award 35 The Thermal Controls Group 40

37 41 18 42 13 Smithkline Beecham Smithkline Beecham Glaxo Wellcome 36 Jabil Circuit, Inc. JBL

3.21 C3 B1 5.7 3.0 5.2 8.0 6.0 7.4

13.9 7 3A.193A.23 (a) (b) (c) (d)

10% (1) Golden Base (2)... 505,062,500 62.24% 505,062,500 46.68% TPG Star (3)... 204,250,170 25.17% 146,549,000 13.55% TPG Biotech (4)... 102,124,830 12.59% 73,273,000 6.77% (1) (2) Golden Base 50%Golden Base Golden Base Golden Base 50%Golden Base Golden Base (3) David Bonderman James CoulterTPG Star 146,549,000 ANT Holdings TPG204,250,170 TPG StarTPG Star, L.P. TPG Star, L.P. TPG Star GenPar, L.P. TPG Star GenPar, L.P. TPG Star GenPar Advisors, LLC TPG Star GenPar Advisors, LLCTPG Holdings I, L.P. TPG Holdings I, L.P. TPG Holdings I-A, LLC TPG Holdings I-A, LLCTPG Group Holdings (SBS), L.P. TPG Group Holdings (SBS), L.P. TPG Group Holdings (SBS) Advisors, Inc. TPG Group Holdings (SBS) Advisors, Inc.David Bonderman James Coulter (4) David Bonderman James CoulterTPG Biotech 73,273,000 ANT Holdings TPG102,124,830 TPG BiotechTPG Biotechnology Partners III, L.P. TPG Biotechnology Partners III, L.P. TPG Biotechnology GenPar III, L.P. TPG Biotechnology GenPar III, L.P. TPG Biotechnology GenPar III Advisors, LLC TPG Biotechnology GenPar III Advisors, LLCTPG Holdings I, L.P. TPG Holdings I, L.P. TPG Holdings I-A, LLC TPG Holdings I-A, LLCTPG Group Holdings (SBS), L.P. TPG Group Holdings (SBS), L.P. TPG Group Holdings (SBS) Advisors, Inc. TPG Group Holdings (SBS) Advisors, Inc. David Bonderman James Coulter

10%

626,250,000,000 0.00000008 50,100 811,437,500 0.00000008 64.915 811,437,500 0.00000008 64.915 270,479,000 0.00000008 21.638 1,081,916,500 0.00000008 86.553 (a) (b) (c) (a) 20%

(b) (a) (b) (c) 10% (a) (b) (c)

% % %... 930,427 65.8 1,479,787 61.8 1,524,555 57.2... 841,334 59.5 1,230,340 51.4 1,167,767 43.8... 89,093 6.3 249,447 10.4 356,788 13.4... 483,558 34.2 915,251 38.2 1,143,423 42.8... 184,059 13.0 625,493 26.1 838,562 31.4... 299,499 21.2 289,758 12.1 304,861 11.4... 1,413,985 100.0 2,395,038 100.0 2,667,978 100.0 % % %... 90,833 9.8 169,634 11.5 222,160 14.6... 70,721 8.4 79,277 6.4 86,289 7.4... 20,112 22.6 90,357 36.2 135,871 38.1... 144,248 29.8 310,237 33.9 441,043 38.6... 107,144 58.2 270,036 43.2 398,643 47.5... 37,104 12.4 40,201 13.9 42,400 13.9... 235,081 16.6 479,871 20.0 663,203 24.9

% % %... 50,397 5.4 107,316 7.3 109,858 7.2... 40,626 4.8 47,100 3.8 44,970 3.9... 9,771 11.0 60,216 24.1 64,888 18.2... 59,082 12.2 116,518 12.7 204,996 17.9... 46,220 25.1 103,399 16.5 194,741 23.2... 12,862 4.3 13,119 4.5 10,255 3.4... 109,479 7.7 223,834 9.3 314,854 11.8... (21,789) (31,449) (59,317)... 87,690 6.2 192,385 8.0 255,537 9.6

... (37,699) (251,274) (383,235)... (66,845) (63,019) (57,599)... 108,201 459,611 378,104... 3,657 145,318 (62,730) 1 2 1 18.0%23.4%6.9% 10.7% 1 8.7% 1 II 64% II 54% 1 Frost & Sullivan II II II II

2 26,5003,500900 70% 3 1,250 20% 3 1,414.0 2,668.0 37.4% 235.1 663.2 68.0% 2 Frost & Sullivan 4

162 29% 28% 15.8%50.3% 1.6%5.2% 29% 28% 57.2 78.0 55.336.9 26.6 65.5 29.0

58.2% 43.2% 47.5% NT Pharma (Group) Co., Ltd. NT Pharma (Group) Co., Ltd. NT Pharma (Group) Co., Ltd. NT Pharma (Group) Co., Ltd 12.7% 18.9% 37.4% 8,500 I

614 III 74 II7.6% 841.31,230.3 1,167.8 17.8% 53.8% 89.1249.4 356.8 100.1% 184.1

625.5838.6 113.4% 80.6% 19.3% 36.5%44.8% 54.1% 75.1%80.6% 22.6% 58.2%36.2% 43.2% 38.1% 47.5% II A+C

31.3%39.2% 4 II A+C Meningococcal ACYW 19.7% 13.9% 18.5% 4 Frost & Sullivan

8.4% 6.4% 7.4%

1 2.4 3.7 5.1 6.4

4.9 15.6 5.5 4.5% 6.6% 1.6% 48.5 52.9 72.1 3.4% 2.2% 2.7%26.4%, 8.5% 8.6%

2.4% 4.7% 7.2% % % %... 930,427 65.8 1,479,787 61.8 1,524,555 57.2... 841,334 59.5 1,230,340 51.4 1,167,767 43.8... 89,093 6.3 249,447 10.4 356,788 13.4... 483,558 34.2 915,251 38.2 1,143,423 42.8... 184,059 13.0 625,493 26.1 838,562 31.4... 299,499 21.2 289,758 12.1 304,861 11.4... 1,413,985 100.0 2,395,038 100.0 2,667,978 100.0

Glipizide 26.4% 8.5% 8.6% 29.8% 22.4% 30.7% 137.8 118.0 165.6 53.4 50.0 71.2

% % %... 839,594 71.2 1,310,153 68.4 1,302,395 65.0... 770,613 65.4 1,151,063 60.1 1,081,478 53.9... 68,981 5.8 159,090 8.3 220,917 11.1... 339,310 28.8 605,014 31.6 702,380 35.0... 76,915 6.5 355,457 18.6 439,919 21.9... 262,395 22.3 249,557 13.0 262,461 13.1... 1,178,904 100.0 1,915,167 100.0 2,004,775 100.0 % % %... 1,163,757 82.3 1,912,316 79.8 1,982,422 74.3 (1)... 15,147 1.1 2,851 0.1 22,353 0.8... 1,178,904 83.4 1,915,167 79.9 2,004,775 75.1 (1)

% % %... 90,833 9.8 169,634 11.5 222,160 14.6... 70,721 8.4 79,277 6.4 86,289 7.4... 20,112 22.6 90,357 36.2 135,871 38.1... 144,248 29.8 310,237 33.9 441,043 38.6... 107,144 58.2 270,036 43.2 398,643 47.5... 37,104 12.4 40,201 13.9 42,400 13.9... 235,081 16.6 479,871 20.0 663,203 24.9 48.2 7.7 28.7 46.0 6.1 25.3 44.3 1.78.1

44.3 108.1 237.4 354.5 % % %... 32,027 2.3 52,795 2.2 74,301 2.8... 33,253 2.3 63,399 2.6 98,277 3.7... 8,350 0.6 50,421 2.1 68,004 2.5... 9,021 0.6 23,442 1.0 54,916 2.1... 8,470 0.6 12,997 0.5 24,670 0.9... 1,486 0.1 9,701 0.4 (1)... 17,008 1.2 32,878 1.4 24,587 0.9... 108,129 7.6 237,418 9.9 354,456 13.3 (1) 43.1 56.0 90.1

% % %... 10,691 0.8 12,993 0.5 14,268 0.5... 7,124 0.5 6,319 0.3 8,481 0.3... 5,262 0.3 5,528 0.2 6,227 0.2... 5,651 0.4 2,998 0.1 3,679 0.1... 2,631 0.1 14,299 0.6... 1,600 0.1 2,467 0.1 4,719 0.2... 748 0.1 2,606 0.1 1,732 0.1 (1)... 12,071 0.9 20,457 0.9 36,651 1.4... 43,147 3.1 55,999 2.3 90,056 3.4 (1) % % %... 50,397 5.4 107,316 7.3 109,858 7.2... 40,626 4.8 47,100 3.8 44,970 3.9... 9,771 11.0 60,216 24.1 64,888 18.2... 59,082 12.2 116,518 12.7 204,996 17.9... 46,220 25.1 103,399 16.5 194,741 23.2... 12,862 4.3 13,119 4.5 10,255 3.4... 109,479 7.7 223,834 9.3 314,854 11.8... (21,789) (31,449) (59,317)... 87,690 6.2 192,385 8.0 255,537 9.6

... 109,479 223,834 314,854... (25,674) (37,380) (96,163)... 48,196 7,670 28,698... (44,311) (1,739) 8,148... (14,277) (17,128) (45,379)... 73,413 175,257 210,158 14.3 17.1 45.4 NT HoldingsTPG AA NT Holdings ANT Holdings NT Holdings NT Holdings NT Holdings A A TPG

... 73,413 175,257 210,158... 19,429 41,228 56,012... 6,427 21,895 28,925... (17) (1)... (9,219) (5,348) (7,901)... 3,086 2,684 4,740... (3,294) (1,115)... 176 923 87... 268... 20,150 58,087 80,748 25% 5% 10% 10% 25% 25%

20.2 58.1 80.7 27.4% 33.1% 38.4% 6 3.8 11.9 33% 25% 15% 25% 25%

... 1,413,985 100.0 2,395,038 100.0 2,667,978 100.0... (1,178,904) (83.4) (1,915,167) (80.0) (2,004,775) (75.1)... 235,081 16.6 479,871 20.0 663,203 24.9... 48,196 3.4 7,670 0.3 28,698 1.1... (44,311) (3.1) (1,739) (0.1) 8,148 0.3... (108,129) (7.6) (237,418) (9.9) (354,456) (13.3)... (43,147) (3.1) (55,999) (2.3) (90,056) (3.4)... 87,690 6.2 192,385 8.0 255,537 9.6... (14,277) (1.0) (17,128) (0.7) (45,379) (1.7)... 73,413 5.2 175,257 7.3 210,158 7.9... (20,150) (1.4) (58,087) (2.4) (80,748) (3.0)... 53,263 3.8 117,170 4.9 129,410 4.9 10 2,395.0273.011.4% 2,668.0 1,479.844.8 3.0%1,524.6 1,230.3 62.55.1%1,167.8

249.4 107.443.0%356.8 Meningococcal ACWY A+C A+C 2.0% 0.9% 18.8% 6.7% 6.1% 2.3% 915.3228.1 24.9%1,143.4 625.5 213.134.1%838.6 289.8 15.15.2%304.9

1,915.289.64.7% 2,004.8 479.9183.3 38.2%663.2 20.0% 24.9% 169.652.631.0% 222.2 11.5% 14.6% 79.3 7.08.8%86.3 6.4% 7.4% 90.4 45.550.4%135.9 36.2% 38.1% 310.2130.8 42.2%441.0 33.9% 38.6% 270.0 128.647.6%398.6

43.2% 47.5% 40.2 2.25.5%42.4 13.9% 7.721.0 28.7 19.2 8.1 1.7 7.6 237.4117.149.3% 354.5 9.9% 13.3% 56.034.160.8% 90.1 2.3% 3.4%

255.5 192.4 8.0% 9.6% 107.32.6 2.4%109.9 47.1 2.14.5%45.0 60.2 4.77.8%64.9 116.588.5 75.9%205.0 103.491.388.3%194.7 13.1 2.821.8%10.3 17.128.3 45.4

58.122.639.0% 80.7(i) (ii) (iii) 33.1% 38.4% 117.212.2 10.4%129.4 4.9% 1,414.0981.069.4% 2,395.0 930.4549.4 59.0%1,479.8 841.3 389.046.2%1,230.3 89.1 160.3180.0%249.4 48.6

104.8 483.6431.7 89.3%915.3 239.8% 184.1 441.4239.8%625.5 33.6113.2 299.5 9.73.3%289.8 1,178.9736.362.5% 1,915.2 235.1244.8 104.1%479.9 16.6% 20.0%

90.878.886.8% 169.6 9.8% 11.5% 70.7 8.612.1%79.3 8.4% 6.4% 20.1 70.3349.3%90.4 22.6% 36.2% 144.2166.0 115.1%310.2 29.8% 33.9% 107.1 162.9152.0%270.0 58.2% 43.2% 37.1 3.18.3%40.2 12.4% 13.9%

48.240.584.1% 7.7 44.342.6 1.7 108.1129.3119.6% 237.4 7.6% 9.9% 43.112.929.8% 56.0 3.1% 2.3% 192.4 87.7 119.4%104.7 6.2% 8.0% 50.456.9 112.9%107.3

40.6 6.515.9%47.1 9.8 50.4 60.2 59.157.4 97.2%116.5 46.2 57.2123.7%103.4 12.9 0.22.0%13.1 14.32.820.0% 17.1 20.2 188.3%37.9 58.1 53.363.9 120.0%117.2 3.8% 4.9%

74 Frost & Sullivan II 7.6% 1,365.4 416.9

19.0% 26.2% 30.5%... 64,884 66,934 212,240... (37,699) (251,274) (383,235)... (66,845) (63,019) (57,599)... 108,201 459,611 378,104... 3,657 145,318 (62,730)... 66,934 212,240 149,810 383.2 297.1 680.3(i) 298.1(ii) 525.4

(iii) 84.9 228.1 251.3 205.1 456.4(i) 105.3 (ii)646.3 (iii) 17.8 313.0 37.7 93.4 131.1(i) 43.5 (ii)236.8 (iii) 6.6 155.8 57.6 51.2 63.0 63.6 66.8 (i) 72.1 (ii) 27.1

378.1 (i) 326.1 (ii) 98.2 459.6 (i) 325.1 (ii) 151.7 108.2 (i) 35.2(ii) 14.3 157.7... 125,690 231,016 527,054 457,483... 575,514 1,213,754 1,738,213 1,746,565... 51,262 55,990 47,080 45,983... 67,803 212,240 154,913 143,457... 820,269 1,713,000 2,467,260 2,393,488... 563,188 1,042,657 1,358,270 1,284,413... 186,497 440,719 833,687 836,684... 70,000 6,500... 12,823 54,931 51,941 54,710... 762,508 1,608,307 2,250,398 2,175,807... 57,761 104,693 216,862 217,681

57.8 104.7 216.9 217.7... 2,560 9,899 7,397... 2,221 3,472 1,502... 120,838 217,591 518,100... 71 54 55... 125,690 231,016 527,054 231.0527.1 (i) (ii)

(iii) 1.90.4% 125.7 83.8%231.0 % % %... 114,529 91.1 208,049 90.1 380,032 72.2... 3,925 3.1 16,513 7.1 92,385 17.5... 6,096 4.9 2,544 1.1 53,933 10.2... 1,140 0.9 3,910 1.7 704 0.1 125,690 100.0 231,016 100.0 527,054 100.0 527.1153.229.1% (1) 32 34 69 (1) 365 82,236,000 32 3469 (i) (ii) (iii)

... 532,403 1,083,657 1,544,291... 1,870 27,162 22,419... 37,755 99,686 170,837... 3,486 2,531 52... 718 614... 575,514 1,213,754 1,738,213 % % %... 413,392 77.4 928,286 83.6 886,616 56.6... 84,392 15.8 127,522 11.5 319,321 20.4... 24,580 4.6 44,412 4.0 149,300 9.5... 7,214 1.3 10,517 0.9 207,109 13.2... 4,695 0.9 82 4,364 0.3... 534,273 100.0 1,110,819 100.0 1,566,710 100.0

42.4% 57.6% % %... 384,225 43.3 502,391 56.7 886,616... 170,660 53.4 148,661 46.6 319,321... 62,704 42.0 86,596 58.0 149,300... 46,117 22.3 160,992 77.7 207,109... 1,077 24.7 3,287 75.3 4,364... 664,783 42.4 901,927 57.6 1,566,710 % %... 340,827 36.7 587,459 63.3 928,286... 74,406 58.4 53,116 41.6 127,522... 17,152 38.6 27,260 61.4 44,412... 5,374 51.1 5,143 48.9 10,517... 82 100.0 82... 437,759 39.4 673,060 60.6 1,110,819 % %... 191,010 46.2 222,382 53.8 413,392... 53,246 63.1 31,146 36.9 84,392... 5,512 22.4 19,068 77.6 24,580... 2,347 32.5 4,867 67.5 7,214... 2,476 52.7 2,219 47.3 4,695... 254,591 47.7 279,682 52.3 534,273 534.3 1,110.8

1,566.7(i)(ii) (iii) 150 1.8% 2.4%240 28.4% 120

250.9 1,566.7 )217.513.9%... 664,783 49,408 7.4... 901,927 168,090 18.5 1,566,710 217,498 13.9 % %... 8,332 8.0 96,347 92.0 104,679... 27,082 40.6 39,624 59.4 66,706... 8,718 54.3 7,335 45.7 16,053... 4,576 16.1 23,838 83.9 28,414... 700 42.5 946 57.5 1,646... 49,408 22.7 168,090 77.3 217,498 643.5 a. 188.9 82.8% b. 41

c. d. e. 15.9% b c d e f. g. h. 17 50 i. 60 180 6090... 5,194 5,030 13,268... 8,238 3,109... (164) (3,782)... 5,030 13,268 12,595

5.7 14.4 17.5 5.0 13.3 12.6 8.2 3.1 (1)... 109 125 183 (1) 365 308,972,000 109 125 183 (i) (ii) 37.8 99.7 170.8

28.0 51.3 56.0 47.1 67.8 212.2 154.9... 343,070 617,238 781,891... 158,824 309,780 422,675... 36,564 69,623 121,194... 17,094 18,724... 3,379 7,559 13,786... 21,351 21,363... 563,188 1,042,657 1,358,270

(%) (%) (%)... 305,475 89.0 581,580 94.2 481,471 61.6... 28,438 8.3 31,975 5.2 224,312 28.7... 3,856 1.1 2,007 0.3 6,332 0.8... 5,301 1.6 1,676 0.3 69,600 8.9... 176 0.0... 343,070 100.0 617,238 100.0 781,891 100.0 90 60 90 60180 (1)... 82 92 127 (1) 365 183,499,000 92 127 82 92

781.9159.520.4% 158.8 309.8 422.7 NT Holdings 28(c) 21.4 21.4 2.3 6.7 36.6 69.6 121.2 8.1 24.5 0.3 17.1... 9,000 25,849 518,005 599,893... 176,628 414,870 310,579 231,735... 5,103 5,056... 869... 186,497 440,719 833,687 836,684

... 186,497 440,719 833,687 836,684 186.5 440.7 833.7 220.6 437.2 646.4177.5 414.9 310.6... 73,583 130,826 186,372... 20,845 52,971... 11,441 6,263... 66,339 432,672 366,694... 51,262 45,562 25,189... 202,625 636,168 631,226 587.8 NT Holdings 24

25.0 25.0 50.0 3.1 70.0 5.35% 100 6.5 4.86%

90.7 83.7 80.1 165.0 15.4

... 7,965 7,456 6,369... 9,137 6,831 3,340... 17,102 14,287 9,709... 43,353 13,864 10,883... 12,693 10,184 56,046 24,048 10,883

5.9% 0.7% 3.3% 30 240 9.2% 7.0% 5.0% 27.0% 21.0% 13.8%

... 4.86% 129,757 1.06% 365,203 2.05% 690,914 10.46% 5.91% 6.12%... 5.35% 70,000 4.86% 6,500 129,757 435,203 697,414... 0.75% (42,410) 0.75% (36,845) 2.22% 129,757 392,793 660,569 ------------- ------------- -------------... 1.70% 1.95% 2.11% 5.18% 56,740 4.75% 75,516 6.39% 142,773... 0.36% 0.36% 0.01% 1.71% (51,262) 1.71% (13,580) 1.91% (10,235)... 0.13% 0.01% 0.01% 0.36% (67,803) 0.36% (212,240) 0.36% (154,913) (62,325) (150,304) (22,375) ------------- ------------- -------------... 67,432 242,489 638,194 25 117,000 282,000 42,000

5% 0.8 2.4 2.4 5% 3.5 2.6... 6.5 7.6 1.000.8509

11.18... 0.00600.0071 1,081,916,500 1.000.8509

4.29... 154.78... 0.83... 1.10...... 154.51... 19.15... 173.66 13.13 13.19 13.13 13.19

1,256.0 5.27 25%314.0 5.27 25%314.0 5.27 70%

10%125.6 5.27 20%251.2 5.27 20%251.2 5.27 10% 437.9 5.27 65.7 5.27

(1) (a)

(b) (c) (d) (e) (f) (g) (h) (i) (j) (k) (l) (m)

(n) (1) (2) (3) (4) (2) (a) (b) (c) (d) (e)

(f) (g) (a) (b) (c) (a) (b) (d) (a) (b) (c) (a) (b) (c) (a) (b) (c)

(a) (b) (c) (i) (ii) (iii)(i) (ii)(iv) (i) (ii) (iii) (i) (ii) (iii) (a)(i) (ii) (iii) (a)(i) (ii) (iii) TPG (i) (ii)

(iii)(i) (ii) (iv) (i) (ii) (iii) (i) (ii) (iii) 10.07 (a) 10.07(2) (b) 10.07 (a) 155 (b) 3% 1%

3.5 30 53,554,000 15% 5.27 187.1

(a) 35,703,500 (b) 144A 321,328,500 35,703,500 10% (i) (ii) 3.3%

A B A 17,852,000 500 B 17,851,500 500AB AB 17,851,500 (i) 15 50(ii) 50 100 (iii) 100 107,110,000(i) 142,813,000(ii) 178,516,000(iii) 30% 40% 50% A B

6.00 6.00 321,328,500 234,775,500 86,553,000 90%

30 40,571,50012,982,500 53,554,000 15% 4.77% (a) (b) (c) (a) (b) (d)

(e) (f) (b) (c) (d) (e) 30 53,554,000 15% Golden Base TPG Golden Base TPG 53,554,00015% Golden Base TPG 10.07(1)(a)

10.07(3)(a) (b) Golden Base TBG Golden Base TBG 1% 0.003%0.005% 6.004.54

10% 5.27 4.54 6.00 1,256.0

(a) (b) (c) 30 155

(i) (ii) (i) (ii)

(i)(ii) (iii) 18 S (www.hkeipo.hk)

1. www.hkeipo.hk (1) 8 52 2 68 8 13

(2) 1 3 341-343 B 608 21 2 101 (3) 10 399 399 720 722 54 1 3-4 (4) 45 361 4 251 128 1992

(a) (b) (c) (d) (a)

(b) (i) (ii) (c) (i) (ii) (d) (i) (ii) 2. eipo www.hkeipo.hk www.hkeipo.hk www.hkeipo.hk

www.hkeipo.hk 500500 www.hkeipo.hk www.hkeipo.hk www.hkeipo.hk

3. 2979 7888 (https://ip.ccass.com) 199 2 (a) (b)

40 500500

40 40 342E (i) (ii) 4.

www.hkeipo.hk www.hkeipo.hk www.hkeipo.hk www.hkeipo.hk www.hkeipo.hk www.hkeipo.hk

17,851,50050% www.hkeipo.hk 5. 6.00 1% 0.003% 0.005%500 3,030.24 17,851,500

6. 1% 0.003%0.005% 1% 0.003%0.005% 6.00 1% 0.003%0.005% 7.

www.hkeipo.hk 24 www.hkeipo.hk www.hkeipo.hk (1) (1) (1) (1) (1) 1 24

8. 8 9. www.ntpharma.comwww.hkexnews.hk www.ntpharma.comwww.hkexnews.hk www.tricor.com.hk/ipo/result www.tricor.com.hk/ipo/result www.ntpharma.com www.tricor.com.hk/ipo/result 3691 8488

10. (a) (www.hkeipo.hk) (www.hkeipo.hk) (www.hkeipo.hk) 40 342E (www.hkeipo.hk) (www.hkeipo.hk)

(b) (c) (d) www.hkeipo.hk (www.hkeipo.hk)

50% 11. 6.00 (a) (i) (ii) (b) (i) (ii) (iii) 1% 0.003%0.005%

1,000,0001,000,000 (b) 1,000,000 1,000,000 1,000,000

12. 500 1011 13.

10 8 22 3 A NT Pharma (Group) Co., Ltd. Kimford Investment Limited Goldwise Resources Limited Tai Ning Pharmaceutical (Investment) Company Limited Farbo Investment Limited Humford Limited

C 31 AC 3.340 A

A NT Pharma (Group) Co., Ltd. NT Pharma (Group) Co., Ltd. NT Pharma (Group) Co., Ltd. B NT Pharma (Group) Co., Ltd. B NT Pharma (Group) Co., Ltd.

NT Pharma (Group) 2 100% Co., Ltd. Kimford Investment Limited 1 100% Kimford Goldwise Resources Limited 1 100% Tai Ning Pharmaceutical 1 100% (Investment) Company Limited Farbo Investment Limited 1 100% Humford Limited 1 100% NTP (China) Investment 15,000,000 100% Co., Limited NT Pharma (HK) Limited 2 100% 2,000,000 100% 100% 10,000,000 100% 20,000,000 3,370,000 100% 100% 100,000,000

100% 50,000,000 80% (i) 55,625,000 11,851,401 100% 100% 166,600,000 100,000 100% 20,030,000 100% (i) 80%Kimford Kimford44.5 80% Kimford 80 20 800,000 800,000

B 1 C... 2 1,413,985 2,395,038 2,667,978... (1,178,904) (1,915,167) (2,004,775)... 235,081 479,871 663,203... 3 48,196 7,670 28,698... 4 (44,311) (1,739) 8,148... (108,129) (237,418) (354,456)... (43,147) (55,999) (90,056)... 87,690 192,385 255,537... 5(a) (14,277) (17,128) (45,379)... 5 73,413 175,257 210,158... 6(a) (20,150) (58,087) (80,748)... 53,263 117,170 129,410... 53,263 117,170 128,610... 800... 53,263 117,170 129,410

2... 53,263 117,170 129,410... 15,284 (86) 11,985... 68,547 117,084 141,395... 68,547 117,084 140,595... 800... 68,547 117,084 141,395

3 C... 11 86,666 163,469 208,859... 11 15,633 15,309 32,477 102,299 178,778 241,336... 11,441 10,444 2,397... 12 42,908 39,904 37,174... 13 1,250 1,250 1,250... 21(b) 899 3,812 5,919 158,797 234,188 288,076 -------------- -------------- --------------... 14 125,690 231,016 527,054... 15 575,514 1,213,754 1,738,213... 16 51,262 55,990 47,080... 17 67,803 212,240 154,913 820,269 1,713,000 2,467,260 -------------- -------------- --------------... 18 563,188 1,042,657 1,358,270... 19 186,497 440,719 833,687... 20 70,000 6,500... 21(a) 12,823 54,931 51,941 762,508 1,608,307 2,250,398 -------------- -------------- --------------... 57,761 104,693 216,862 -------------- -------------- --------------... 216,558 338,881 504,938 -------------- -------------- --------------

C... 21(b) 882 -------------- 2,005 -------------- 2,661 --------------... 215,676 336,876 502,277... 24...... 200,546 321,746 487,147... 200,546 321,746 487,147... 15,130 15,130 15,130... 215,676 336,876 502,277

4 24(b) 24(c)(i) 24(c)(ii)24(c)(iii) 24(c)(iv)... 22,528 28,336 8,256 72,879 131,999 15,130 147,129... 53,263 53,263 53,263... 15,284 15,284 15,284... 15,284 53,263 68,547 68,547 ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------... 8,195 (8,195)... 37,812 36,531 8,256 117,947 200,546 15,130 215,676... 117,170 117,170 117,170... (86) (86) (86)... (86) 117,170 117,084 117,084 ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------... 4,116 4,116 4,116... 8,370 (8,370)... 37,726 44,901 8,256 4,116 226,747 321,746 15,130 336,876... 128,610 128,610 800 129,410... 11,985 11,985 11,985... 11,985 128,610 140,595 800 141,395... (800) (800)... 24,806 24,806 24,806... 20,458 (20,458)... 49,711 65,359 8,256 28,922 334,899 487,147 15,130 502,277 ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------

5 C... 73,413 175,257 210,158... 3 (1,722) (1,186) (619)... 3 (45,980)... 4 20,259 619 (527)... 4 16,493... 5(a) 14,277 17,128 45,379... 5(b) 4,116 24,806... 5(c) 324 324 360... 5(c) 4,595 4,117 4,393... 5(c) 6,096 4,864 12,671... 5,627 (127) 446 93,382 205,112 297,067... (43,499) (105,326) (298,095)... (236,758) (646,267) (525,400)... 155,806 312,976 228,073... (31,069) (233,505) (298,355)... (8,115)... (6,630) (17,769) (76,765)... (37,699) (251,274) (383,235) -------------- -------------- --------------

C... (72,055) (63,619) (51,167)... (17,528)... (27,087) (4,113) (1,680)... 1,578 255 3,247... 1,722 1,186 619... 1,503 (4,728) 8,910... 27,494 8,000... (66,845) (63,019) (57,599) -------------- -------------- --------------... 584,095 2,067,928 2,085,840... 70,000 16,500... (619,268) (1,812,853) (1,696,263)... (80,000)... (14,277) (17,128) (45,379)... 157,651 151,664 98,206... (800)... 108,201 459,611 378,104 -------------- -------------- --------------... 3,657 145,318 (62,730)... 64,884 66,934 212,240... (1,607) (12) 300... 17 66,934 212,240 149,810

C 1 (a) C 2 834 8 32 (b) A (c)

29 (d) (e) (i)

(ii) (ii) (i) 1(j) (f) 1(j) 50 5-10 5 5 3-5 (g) 1(j) 1(v)

(h) (i) 1(j) 10 (ii) 1(j) 32 (iii) GSP GSP 1(j) (iv) 1(j) 10 (v) 1(j) (vi) 1(j) 5 10

(i) (j) (i)

(ii)

(k) (l) 1(j) (m) (n) (o)

(p) (i) (ii) (q)

(i) (ii)

(r) (i) (i)(ii) 1(r)(ii) (ii) (s) (i)

(ii) (iii) (iv) (t) (u) (v)

(w) (i) (ii) (iii) (iv) (v) (i) (vi) (x) 2... 1,380,405 2,281,867 2,475,328... 33,580 113,171 192,650 1,413,985 2,395,038 2,667,978

10 10% 834 25(a) 10 3... 1,722 1,186 619 22... 45,980... 348 6,076 25,267... 146 408 2,812 48,196 7,670 28,698 4... (20,259) (619) 527... (16,493)... (7,559) (1,120) 7,621 (44,311) (1,739) 8,148

5 (a)... 14,259 12,980 36,801... 2,325 5,507 9,181... 16,584 18,487 45,982 *... (2,307) (1,359) (603) 14,277 17,128 45,379 * 6.14% 8.22% 5.35% 8.22% 5.35% 5.84% (b)... 7,248 10,921 19,973... 49,409 73,977 109,967... 4,116 24,806 56,657 89,014 154,746 10% 22%

5% 20,000 (c)... 324 324 360... 4,595 4,117 4,393... 6,096 4,864 12,671... 551 539 671... 8,071 8,443 8,327 14(b)... 1,163,757 1,912,316 1,982,422

6 (a)... -------------- 3,750 -------------- 11,891 --------------... 19,277 55,204 70,221... 176 923 87 19,453 56,127 70,308 -------------- -------------- --------------... 429 (1,790) (1,451)... 268 697 (1,790) (1,451) -------------- -------------- -------------- 20,150 58,087 80,748

(b)... 73,413 175,257 210,158 (i) (ii) (iii)... 19,429 41,228 56,012... 6,427 21,895 28,925... (17) (1) (iii)... (9,219) (5,348) (7,901)... 3,086 2,684 4,740... (3,294) (1,115)... 176 923 87... 268... 20,150 58,087 80,748

(i) (ii) 16.5% (iii) 33% 25% 15% 15% 15% 25% 18% 20% 22% 24% 25% 9% 10% 11% 24% 25% (iv) 10% 25%5%

7... 5,436 11 5,447...... 215 3 218.................. 5,651 14 5,665

... 2,997 11 3,008........................ 2,997 11 3,008

... 3,135 10 3,145... 601 931 9 2,702 4,243............ 181 181... 181 181... 163 163... 1,126 4,066 19 2,702 7,913 1(p)(ii) 8

8 7... 2,221 2,894 2,021... 139 118 121... 1,331 5,285 2,360 4,343 7,427... 4 4 3 1,000,000... 4 1,000,001 1,500,000... 4 2,500,001 3,000,000... 2 3,000,001 3,500,000... 1 9 A

10 (a)

... 841,334 1,230,340 1,167,767 89,093 249,447 356,788 184,059 625,493 838,562 299,499 289,758 304,861 1,413,985 2,395,038 2,667,978... (770,613 ) (1,151,063 ) (1,081,478 ) (68,981 ) (159,090 ) (220,917 ) (76,915 ) (355,457 ) (439,919 ) (262,395 ) (249,557 ) (262,461 ) (1,178,904 ) (1,915,167 ) (2,004,775 )... 70,721 79,277 86,289 20,112 90,357 135,871 107,144 270,036 398,643 37,104 40,201 42,400 235,081 479,871 663,203... 40,626 47,100 44,970 9,771 60,216 64,888 46,220 103,399 194,741 12,862 13,119 10,255 109,479 223,834 314,854... 162 173 300 153 177 278 5,874 4,628 7,421 2,916 2,002 4,026 9,105 6,980 12,025

(b)... 1,413,985 2,395,038 2,667,978... 109,479 223,834 314,854... (25,674) (37,380) (96,163)... 48,196 7,670 28,698... (44,311) (1,739) 8,148... (14,277) (17,128) (45,379)... 73,413 175,257 210,158

11... 21,324 22,510 152 5,457 3,869 3,926 14,435 71,673 33,554 105,227... (9) (81) (19) (65) (174) (174)... 947 5,040 391 644 53,592 60,614 60,614... (18,472) (12,800) (127) (31,399) (17,376) (48,775)... 2,852 10,657 143 10,416 4,241 4,378 68,027 100,714 16,178 116,892 ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------... 3,443 6,245 27 4,314 1,893 1,660 17,582 1,104 18,686... (2) (15) (11) (40) (68) (68)... 1,437 2,430 29 853 715 632 6,096 324 6,420... (4,376) (5,072) (114) (9,562) (883) (10,445)... 504 3,603 54 5,152 2,597 2,138 14,048 545 14,593 ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------... 2,348 7,054 89 5,264 1,644 2,240 68,027 86,666 15,633 102,299

... 2,852 10,657 143 10,416 4,241 4,378 68,027 100,714 16,178 116,892... 1 1 2 2... 2,202 67 1,818 1,951 103 76,398 82,539 82,539... (12) (1,173) (651) (78) (1,914) (1,914)... 93,445 15,558 (109,003)... 96,297 28,417 198 11,062 5,541 4,404 35,422 181,341 16,178 197,519 ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------... 504 3,603 54 5,152 2,597 2,138 14,048 545 14,593... 132 1,375 29 1,920 731 677 4,864 324 5,188... (5) (642) (345) (48) (1,040) (1,040)... 636 4,978 78 6,430 2,983 2,767 17,872 869 18,741 ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------... 95,661 23,439 120 4,632 2,558 1,637 35,422 163,469 15,309 178,778

... 96,297 28,417 198 11,062 5,541 4,404 35,422 181,341 16,178 197,519... (6) (38) (12) (52) (108) (108)... 4,088 1,636 387 1,957 1,570 3,179 48,027 60,844 17,528 78,372... (2,851) (367) (32) (701) (3,951) (3,951)... 46,307 13,699 (60,006)... 143,841 43,752 212 12,981 7,067 6,830 23,443 238,126 33,706 271,832 ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------... 636 4,978 78 6,430 2,983 2,767 17,872 869 18,741... (3) (6) (8) (28) (45) (45)... 5,209 3,451 40 2,036 769 1,166 12,671 360 13,031... (649) (6) (576) (1,231) (1,231)... 5,196 8,429 115 8,460 3,738 3,329 29,267 1,229 30,496 ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------... 138,645 35,323 97 4,521 3,329 3,501 23,443 208,859 32,477 241,336

(a) 40 47 (b) 73,583,000 130,826,000 186,372,000 (c) 93,445,000 156,136,000 12 GSP... 7,283 9,330 7,030 496 2,663 26,802... (32) (32)... 30,000 87 30,087... 7,283 ------------ 9,330 ------------ 7,030 ------------ 30,000 ------------ 464 ------------ 2,750 ------------ 56,857 ------------... 1,456 6,998 900 9,354... 728 2,332 1,000 535 4,595... 2,184 ------------ 9,330 ------------ ------------ 1,000 ------------ ------------ 1,435 ------------ 13,949 ------------... 5,099 7,030 29,000 464 1,315 42,908

GSP... 7,283 9,330 7,030 30,000 464 2,750 56,857... 760 353 1,113... 7,283 ------------ 9,330 ------------ 7,030 ------------ 30,000 ------------ 1,224 ------------ 3,103 ------------ 57,970 ------------... 2,184 9,330 1,000 1,435 13,949... 728 3,000 389 4,117... 2,912 ------------ 9,330 ------------ ------------ 4,000 ------------ ------------ 1,824 ------------ 18,066 ------------... 4,371 7,030 26,000 1,224 1,279 39,904 GSP... 7,283 9,330 7,030 30,000 1,224 3,103 57,970... (17) (17)... 1,680 1,680... 7,283 ------------ 9,330 ------------ 7,030 ------------ 30,000 ------------ 1,207 ------------ 4,783 ------------ 59,633 ------------... 2,912 9,330 4,000 1,824 18,066... 728 3,000 665 4,393... 3,640 ------------ 9,330 ------------ ------------ 7,000 ------------ ------------ 2,489 ------------ 22,459 ------------... 3,643 7,030 23,000 1,207 2,294 37,174

(a) (b) (c) GSP GSP GSP 15.6% 16.2% 14.2% 13... 1,250 1,250 1,250... 769 769 769... 481 481 481 1,250 1,250 1,250

% % %... 42.0-43.6 42.0-42.9 42.0-42.9... 11.8-210.0 11.8-30.4 11.8-32.4... 15.6 16.2 14.2... 17.9-18.8 13.0-16.6 12.6-17.0... 11.8-150.0 15.2-18.0 14.4-18.1... 15.6 16.2 14.2 14 (a)... 2,560 9,899 7,397... 2,221 3,472 1,502... 120,838 217,591 518,100... 71 54 55 125,690 231,016 527,054 20,845,000 52,971,00019

(b)... 1,161,315 1,908,591 1,977,308... 2,442 3,725 5,114 1,163,757 1,912,316 1,982,422 15... 539,303 1,124,087 1,579,305 15(b)... (5,030) (13,268) (12,595) 534,273 1,110,819 1,566,710... 37,755 99,686 170,837... 3,486 2,531 52... 718 614 575,514 1,213,754 1,738,213 1,720,000 1,576,000 960,000 66,339,000 432,672,000 366,694,00019

(a)... 413,392 928,286 886,616... 84,392 127,522 319,321... 24,580 44,412 149,300... 7,214 10,517 207,109... 4,695 82 4,364 534,273 1,110,819 1,566,710 30240 25(a) (b) 1(j)(i)... 5,194 5,030 13,268... 8,238 3,109... (164) (3,782)... 5,030 13,268 12,595

5,742,000 14,375,000 17,541,000 5,030,000 13,268,000 12,595,000 (c)... 438,232 907,760 918,233 -------------- -------------- --------------... 76,877 137,195 298,448... 4,084 43,793 87,997... 3,449 20,713 214,658... 10,919 251 42,428 95,329 201,952 643,531 -------------- -------------- -------------- 533,561 1,109,712 1,561,764 16 48,000,000 96,720,000 163,712,00018 19

17... 67,803 212,240 154,913 19... (869) (5,103)... 66,934 212,240 149,810 67,136,000 195,870,000 149,785,000 18... 343,070 617,238 781,891... 36,564 69,623 121,194... 17,094 18,724... 3,379 7,559 13,786... 158,824 309,780 422,675... 21,351 21,363 563,188 1,042,657 1,358,270

... 305,475 581,580 481,471... 28,438 31,975 224,312... 3,856 2,007 6,332... 5,301 1,676 69,776 343,070 617,238 781,891 19... 186,497 440,719 833,687

17... 869... 5,103 869 5,103 -------------- -------------- --------------... 176,628 414,870 310,579... 9,000 25,849 518,005 185,628 440,719 828,584 -------------- -------------- -------------- 186,497 440,719 833,687 220,600,000 437,188,000 646,380,000 177,497,000 414,870,000 310,579,000... 73,583 130,826 186,372... 11,441 6,263... 20,845 52,971... 66,339 432,672 366,694... 51,262 45,562 25,189 202,625 636,168 631,226 72,600,000Rich Great International Industries LimitedRich Great Rich Great

181,446,000 Rich Great NT Pharma (Holdings) Company Limited 587,776,000 NT Pharma (Holdings) Company Limited 28,116,000 25(c) 20 5.35 4.86% 21 (a)... 3,750 7,217... 12,823 51,181 44,724 12,823 54,931 51,941

(b)... 3,089 (2,080) (1,780) 61 (710)... (4) (4)... (276) 446 584 (57) 697... 2,813 (1,634) (1,196) (17)... 2,813 (1,634) (1,196) (17)... (73) (2,913) 1,196 (1,790)... 2,740 (4,547) (1,807)... 2,740 (4,547) (1,807)... (79) (1,372) (1,451)... 2,661 (5,919) (3,258)... (899) (3,812) (5,919)... 882 2,005 2,661 (17) (1,807) (3,258)

(c) 1(q) 29,428,000 18,689,000 33,363,000 829,000 6,508,000 6,274,000 18,967,000785,000 (d) 80,329,000 193,386,000 389,718,000 22... 13,255... 32,725 3... (45,980)... 45,980,000 23 NT Pharma (Holdings) Company LimitedNT Holdings NT Holdings NT Holdings

NT Holdings NT Holdings (a)... 19,335,933 10... 19,335,933 10... 19,335,933 10... 7,582,642 10... 7,582,641 10... 7,582,641 10... 1,666,667 10... 1,666,667 10... 1,666,666 10... 3,166,667 10... 3,166,667 10... 3,166,666 10... 533,333 10... 533,333 10... 533,334 10... 666,667 10... 666,667 10... 666,666 10... 400,000 10... 400,000 10... 400,000 10 100,055,723

(b)... 58,007,799... 58,007,799 42,047,924... (10,141,366)... 58,007,799 89,914,357... 16,412,341 NT Holdings58,007,799 0.10 NT Holdings88,714,357 0.101,200,000 70% 9.79.0 (c)... 0.07 0.08 0.07 0.11 0.11 0.08 0.09... 0.12 0.14 0.12 0.17 0.17 0.17 0.17... 0.10 0.10 0.10 0.10 0.10 0.10 70%... 58.46% 58.23% 58.00% 59.51% 58.94% 53.10% 57.19%... 0% 0% 0% 0% 0% 0% 0%... 4.297% 4.378% 4.293% 4.072% 3.415% 3.241% 3.858%

24 (a) (b) NT Pharma (Group) Co., Ltd 2 1 50,100 626,250,000,000 0.00000008 NT Pharma (Group) Co., Ltd.1 0.000000082 1 (c) (i) 1(u) (ii) 10% 50%

(iii) (iv) NT Holdings 1(p)(ii) (d) 19.0% 26.2% 30.5% 25 (a) (i) 30 240 15

9.2% 7.0% 5.0% 27.0% 21.0% 13.8% 27 (ii) (b)... 188,978 188,978 185,628

... 434,002 4,183 10,690 448,875 440,719... 838,689 3,266 7,528 849,483 828,584 (c) (i) (i) 4.86% 1.06% 2.05%... 10.46% 129,757 5.91% 365,203 6.12% 690,914... 5.35% 70,000 4.86% 6,500 129,757 435,203 697,414 0.75%... 0.75% (42,410) 2.22% (36,845) 129,757 392,793 660,569 ------------- ------------- -------------

1.70% 1.95% 2.11%... 5.18% 56,740 4.75% 75,516 6.39% 142,773 0.36% 0.36% 0.01%... 1.71% (51,262) 1.71% (13,580) 1.91% (10,235) 0.13% 0.01% 0.01%... 0.36% (67,803) 0.36% (212,240) 0.36% (154,913) (62,325) (150,304) (22,375) ------------- ------------- -------------... 67,432 242,489 638,194 (ii) 25 117,000 282,000 42,000 (d)

(i)... 26,261... 51,262 42,409 25,119... 5,617 40,550 5,199... (34,784) (81,771) (93,140) (22,746) (69,557)... (92,097) (72,706) 22,095 (64,648) (93,140) (65,134) (69,557) (ii)... 5% 829 5% (2,424) 5% (2,443) (5)% (829) (5)% 2,424 (5)% 2,443... 5% 5% (3,493) 5% (2,608) (5)% (5)% 3,493 (5)% 2,608

(e) 26 (a)... 43,353 13,864 10,883... 12,693 10,184 56,046 24,048 10,883 (b)... 7,965 7,456 6,369... 9,137 6,831 3,340 17,102 14,287 9,709

27 Rich Great Rich Great 15,401,000 28 Rich Great International Industries Limited NT Pharma (Holdings) Company Limited (a)... 9,873 15,161 13,106

(b) 7 8... 9,219 7,814 10,086... 2,270 13,421 9,219 10,084 23,507 5(b) (c) NT Pharma (Holdings) Company Limited... 2,476 2,531 52... 1,010 3,486 2,531 52... 718 614 NT Pharma (Holdings) Company Limited... 155,880 307,463 415,955 Rich Great International Industries Limited... 2,886... 2,259 6,720... 58 58 158,824 309,780 422,675... 21,351 21,363

NT Pharma (Holdings) Company Limited NT Pharma (Holdings) Company Limited 60 (d)... 72,600 141,446 317,775 (e) NT Pharma (Holdings) Company Limited... 141,446 242,775 (f) 72,600,000 60,314,000Rich Great Rich Great Rich Great 29